Skip to main content

Tmax

pharmacology

The time from administration to the highest concentration a substance reaches in blood — the peak, in pharmacokinetic notation. It records when a substance is most concentrated, not when its effects are strongest, and the two can diverge; for most compounds in this index Tmax has never been measured in humans.

Tmax is the time that elapses between administration and the moment a substance reaches its highest concentration in blood. It is a standard pharmacokinetic parameter — part of the same family as Cmax (the peak concentration itself) and half-life — that appears whenever researchers characterize how a drug moves through the body.

Peak blood concentration and peak subjective effect are not the same thing. A substance can reach Tmax while the felt experience is still building, or effects may linger well after blood levels have fallen — a divergence that has practical implications for timing and redosing. For many compounds in this index, Tmax has never been formally measured in humans.

How it works · its role

Tmax is determined primarily by the rate of absorption into the bloodstream, and that rate depends heavily on route of administration. Inhalation and intravenous injection deliver a substance directly to circulation; Tmax is then measured in minutes. Oral ingestion is slower: the substance must dissolve, cross the gut wall, and clear the liver before reaching systemic blood. Sublingual and insufflation routes fall between these extremes.

Formulation shapes the curve further. Extended-release tablets release their contents gradually, pushing Tmax later than an immediate-release equivalent would. Food in the stomach can delay absorption significantly. Once in blood, distribution and elimination both begin; Tmax marks the moment absorption stops outpacing clearance. After that point, concentration falls.

Relevance to substances & effects

Tmax is most directly useful for interpreting timing on a substance page. Onset typically begins before the peak, intensity climbs as blood concentration rises toward Tmax, and the character of effects begins to shift as levels fall away.

Redosing before Tmax is reached — when the first dose's full effect has not yet been felt — is a common source of unintended overconsumption, particularly with oral routes where the ascent is slow. Cannabis edibles are the clearest example: absorption can take one to two hours, long enough for a user to assume a dose has failed and take more.

For substances whose metabolites are themselves active, Tmax becomes more complicated. The parent compound may peak early while a pharmacologically active metabolite peaks later — a pattern seen with several benzodiazepines and prodrug opioids, and one that can explain why effects outlast the expected window.

AI-generated · not yet verified by a human reviewer

Harm-reduction reference — not medical advice.

Last updated Aug 24, 2026Report an issue